SS-31 inhibits the inflammatory response by increasing ATG5 and promoting autophagy in lipopolysaccharide-stimulated HepG2 cells

Biochem Biophys Res Commun. 2024 May 28:710:149887. doi: 10.1016/j.bbrc.2024.149887. Epub 2024 Apr 4.

Abstract

SS-31 is a mitochondria-targeting short peptide. Recent studies have indicated its hepatoprotective effects. In our study, we investigated the impact of SS-31 on LPS-induced autophagy in HepG2 cells. The results obtained from a dual-fluorescence autophagy detection system revealed that SS-31 promotes the formation of autolysosomes and autophagosomes, thereby facilitating autophagic flux to a certain degree. Additionally, both ELISA and qPCR analyses provided further evidence that SS-31 safeguards HepG2 cells against inflammatory responses triggered by LPS through ATG5-dependent autophagy. In summary, our study demonstrates that SS-31 inhibits LPS-stimulated inflammation in HepG2 cells by upregulating ATG5-dependent autophagy.

Keywords: ATG5; Autophagosomes; Autophagy; Lipopolysaccharide; SS-31.

MeSH terms

  • Autophagosomes
  • Autophagy*
  • Autophagy-Related Protein 5 / genetics
  • Hep G2 Cells
  • Humans
  • Inflammation
  • Lipopolysaccharides* / pharmacology

Substances

  • Lipopolysaccharides
  • ATG5 protein, human
  • Autophagy-Related Protein 5